SpineX Demonstrates Groundbreaking Technology to Treat Children with Cerebral Palsy

SpineX Publishes Results from First in Human Study Using its Proprietary Non-Surgical and Non-Invasive Device SCiP to Treat children with Cerebral Palsy LOS ANGELES–(BUSINESS WIRE)–#cerebralpalsy–SpineX, Inc., a clinical stage medtech company today announced the groundbreaking results its first in human study in children with cerebral palsy. The study is published in the esteemed medical journal … [Read more…]

Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA: Cefepime/Enmetazobactam Met Criteria for Superiority

SAINT-LOUIS, France & WEIL AM RHEIN, Germany–(BUSINESS WIRE)–Allecra Therapeutics (“Allecra”) announced today that the final results from its Phase 3 ALLIUM trial investigating the combination of cefepime/enmetazobactam in patients with complicated urinary tract infections (cUTIs) have been published in the Journal of the American Medical Association (JAMA). The publication represents the first full analysis of … [Read more…]

Elevated Access, a New Non-Profit Volunteer Pilot Network, Launches with 1000 Volunteers

Free Private Flights for Abortion and Gender Affirming Care SPRINGFIELD, Ill.–(BUSINESS WIRE)–#abortionishealthcare–Elevated Access, a volunteer general aviation pilot network, launched earlier this year to provide free private flights to those seeking access to abortion and gender-affirming care. Following the SCOTUS decision to overturn Roe v Wade, the landscape of abortion access has changed dramatically. Many … [Read more…]

Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

LONDON–(BUSINESS WIRE)–Prokarium Ltd (‘Prokarium’ or the ‘Company’), a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent (Application No. 17/344,065) protects the co-administration of Prokarium’s Salmonella strains with cell therapies to enhance their therapeutic efficacy. … [Read more…]

Myonex Completes Acquisition of Hubertus Clinical Trial and Packaging Business

HORSHAM, Pa.–(BUSINESS WIRE)–Myonex, a leading global clinical trial supply company, announced today the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports the company’s recent growth and strengthens its presence throughout the European Union. “The new Berlin location strengthens our … [Read more…]

Mitsui Chemicals Group to Exhibit at K2022 Trade Fair in Düsseldorf, Germany

TOKYO–(BUSINESS WIRE)–Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) and Mitsui Chemicals Europe GmbH (Düsseldorf, Germany; President: HIRAIWA Takeshi) will exhibit at K2022 – the World’s No.1 Trade Fair for Plastics and Rubber as the Mitsui Chemicals Group. The event is scheduled to be held from October 19–26, 2022 in Düsseldorf, Germany. At … [Read more…]

Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements

INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which aims to close a critical financing gap for social businesses in vulnerable communities. Cowtribe, a leading last-mile veterinary delivery company from Ghana, leverages technology to help … [Read more…]

ONWARD Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury at Home

LIFT Home study evaluated the safety and feasibility of ARC-EX Therapy in the home setting 100% of subjects completed the study with no reported serious adverse events 97% of therapy sessions were successfully completed supporting the feasibility of home use EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical … [Read more…]

Sense and Abacus dx Agree to Distribute Rapid, Instrument-Free Molecular COVID-19 Test in Australia and New Zealand

Instrument-Free Veros™ COVID-19 Produces Lab-Quality Molecular Results in about 15 minutes BOSTON & OXFORD, England & CAMBRIDGE, England & BRISBANE, Australia–(BUSINESS WIRE)–Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement with Abacus dx for the non-exclusive distribution in Australia and New Zealand of Sense’s Veros instrument-free, point-of-care molecular … [Read more…]

Owens & Minor Issues Call for Nominations for Annual Supplier Diversity Awards

Nominations now open for the 2022 Supplier Diversity Awards, an annual program honoring the legacy of Earl G. Reubel, founder of Kerma Medical Products and longtime partner of Owens & Minor Deadline for submissions is Nov. 18; winners will be announced at the Healthcare Supplier Diversity Alliance Annual Meeting on Dec. 8 RICHMOND, Va.–(BUSINESS WIRE)–Owens … [Read more…]